Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Merck presents new series of thrombin inhibitors

May 14, 2002

Benzamidine derivatives from Genentech inhibit serine proteases involved in thrombosis

May 14, 2002

Enrollment completed in phase I trial of DAC:TI in hemodialysis patients with AV shunts

May 14, 2002

Orally available thrombin inhibitor designed at LG Chem

May 14, 2002

Factor Xa inhibitors for undesired thrombosis

May 13, 2002

Wyeth to discontinue development of rPSGL-Ig for myocardial infarction

May 13, 2002

Orally active thrombin inhibitor advances to phase II clinical trials at Boehringer Ingelheim

April 30, 2002

Factor Xa inhibitors and their use in thrombotic disorders

April 26, 2002

Novel factor Xa inhibitors identified at Morphochem

April 17, 2002

Synthesis and use of factor Xa inhibitors described in patent by Lilly

April 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...